Impax Laboratories Inc. (NASDAQ:IPXL)

Bobes915 (81.51) Submitted: 5/18/2010 6:39:53 PM : Start Price: $20.01 IPXL Score: -11.74

Lots of expiring patents in next few years. Looks like good value and growth potential to me.

KepoTaz1952Lime (33.03) Submitted: 5/16/2010 10:20:13 AM : Start Price: $19.99 IPXL Score: -9.47

Lots of drugs in pipeline. Health care plan will help boost price.

MagicDiligence (64.23) Submitted: 5/13/2010 9:37:05 AM : Start Price: $20.02 IPXL Score: -6.92

Impax Pharmaceuticals is a generic drug maker. While the company is a "Magic Formula mirage" due to the 8-week generic Flomax exclusivity period, it still is an attractive Magic Formula stock for a variety of reasons.

See my full CAPS review here:
http://caps.fool.com/Blogs/ViewPost.aspx?bpid=391192&t=01003070853754792343

eyedoc2 (< 20) Submitted: 4/14/2010 5:43:28 PM : Start Price: $17.49 IPXL Score: +10.71

Growing generic drug first-to-market wins allow 6 month exclusive rights and extra profits (50 or more on file). Also payments to hold off new generics from name brand makers will push earnings growth ahead of estimates, lifting stock price.

MrFellow13 (< 20) Submitted: 4/12/2010 4:22:56 AM : Start Price: $16.94 IPXL Score: +15.01

Provides generic prescription. Socialist health care requires generic prescriptions. Over $200 billion in drug patents expire in the next 2 years.

donsguesswork (< 20) Submitted: 3/22/2010 10:17:34 PM : Start Price: $17.48 IPXL Score: +8.32

IPXL, is a technology based, specialty pharmaceutical company focused on bioequivalent and Brand Name pharmaceuticals. In generics the company is focused on controlled-release generic versions of brand-name pharmaceuticals covering a range of therapeutic areas. In the brand-name pharmaceuticals the company is developing products for treatment of central nevous system disorders. The company's brand name portfolio consists of development-stage projects to which the company applies its formulation & development expertise to develop differentiated, modified or controlled-release versions of marketed drug substances.

jbrt (< 20) Submitted: 1/6/2010 6:26:04 PM : Start Price: $14.06 IPXL Score: +34.61

LOTS OF ROOM FOR EXPANSION

fourthreethree (85.71) Submitted: 10/12/2009 3:04:16 PM : Start Price: $9.27 IPXL Score: +106.21

just ignoring advice and following my brain's "gut."